All news

T. Rowe Price reports an Anterix (ATEX) stake that includes a small-cap fund holding 5.6%.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

T. Rowe Price Investment Management, Inc. has filed an amended passive investment disclosure (SCHEDULE 13G/A) for Anterix Inc. (ATEX), reporting an aggregate beneficial ownership of 3,204,964 common shares, which represents 16.3% of the class. The filing specifies that T. Rowe Price Small-Cap Stock Fund holds 1,055,994 shares, or 5.6% of the class, within its investment portfolio.

Read original source

ATEX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.